ReviewAIMS microbiology2025
Screening strategies and production of biosurfactants (BSs)/bioemulsifiers (BEs) from marine yeasts and fungi.
Review in AIMS microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The unique characteristics of the marine ecosystem support the existence of microorganisms with exceptional metabolic potential, enabling them to produce high-value bioactives. Among these, biosurfactants (BSs) and bioemulsifiers (BEs) are notable multifaceted molecules, distinguished by their unique structural, molecular, and functional properties. Marine yeasts and fungi produce BSs/BEs with distinctive properties in terms of stability under extreme conditions. It is important to mention here that in comparison to marine bacteria, yeast and fungi of the same habitat have been explored only intermittently. Some of the BSs/BEs producing bacteria may prove to have some pathogenic or cytotoxic traits or components, while most yeasts are mainly classified as Generally Recognized As Safe (GRAS) (by the Food and Drug Administration-FDA, USA), making their BSs/BEs products more amenable for a wide range of applications. The diverse and unique potential of surface-active agents is further enhanced by the endosymbiotic associations often found in marine yeasts and fungi. These microorganisms are acknowledged to produce glycolipidic (rhamnolipids, sophorolipids, and mannosylerythritol lipids) or glycolipoproteins. The SL have been reported well for their strong antimicrobial activity, including effectiveness against drug-resistant pathogens, making them promising candidates for controlling foodborne pathogens in the food industry. Furthermore, these microorganisms can utilize a broad range of carbon sources from simple substrates, like glucose and glycerol, to complex feedstocks such as food, oil, agricultural waste, and wastewater, which not only support their growth but also promote the production of substantial yields of these BSs/BEs. In this review, we endeavor to explore BSs/BEs from marine yeasts and fungi, including the screening, characterization, identification, production, and importance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.